Latest Security News

CONNEQT Health has raised $3.1 million through an institutional placement to fuel growth of its Pulse vascular health device, supported by both new and existing investors including its largest shareholder.

Riedel Resources has successfully raised approximately $1.78 million through a pro rata entitlement offer and subsequent shortfall placement, positioning the company to advance its Kingman Gold Project.

Saunders International has landed a $10.4 million contract to build new water storage infrastructure in South West Sydney, reinforcing its foothold in the growing water infrastructure sector.

Blue Star Helium has successfully started helium production at its Pinon Canyon plant, marking a key milestone as it prepares for commercial sales and expansion in 2026.

Blue Star Helium Limited has raised up to A$8.2 million through a placement and rights issue to fund production scale-up and further drilling at its Galactica helium project in North America.

Gratifii Limited is set to transform its digital marketing and engagement capabilities through the acquisition of New Zealand’s Mosh Digital and the Future Pass digital wallet platform, backed by a $2.5 million capital raise.

Regal Investment Fund has announced an estimated ordinary dividend of AUD 0.12 per unit for the half-year ending December 2025, alongside a full Dividend Reinvestment Plan available to eligible investors.

High-Tech Metals has intersected visible gold in multiple zones at its Wagtail deposit, advancing drilling and development efforts toward a potential near-term mining decision.

Artemis Resources has secured a joint venture to earn a 60% stake in the Sharon Dam IOCG copper target, backed by a $220k government grant and planned drilling in early 2026. This deal extends Artemis’ footprint in a promising underexplored copper province in Western Australia.

Seven West Media shareholders convened on 22 December 2025 to vote on a landmark acquisition by Southern Cross Media Group, potentially reshaping Australia's media landscape. The proposed scheme promises a combined media powerhouse spanning television, digital, audio, and publishing.

Tartana Minerals has received $1 million from a new investor as part of a $1.275 million placement, setting the stage for debt reduction and upcoming shareholder decisions.

Neuren Pharmaceuticals has secured Health Canada approval to expand its pivotal Phase 3 trial of NNZ-2591 for Phelan-McDermid syndrome into Canadian sites, complementing ongoing US enrolment.